These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7986302

  • 1. Efficacy and safety of fluvastatin in hyperlipidaemic patients with non-insulin-dependent diabetes mellitus.
    Jokubaitis LA, Knopp RH, Frohlich J.
    J Intern Med Suppl; 1994; 736():103-7. PubMed ID: 7986302
    [Abstract] [Full Text] [Related]

  • 2. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
    Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D.
    Am J Med; 1994 Jun 06; 96(6A):69S-78S. PubMed ID: 8017470
    [Abstract] [Full Text] [Related]

  • 4. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M, Valacio R, Reckless JP, Ghosh AK, Findlay IN, Ghosh MK, Passmore AP, Fulcher RA.
    Coron Artery Dis; 1998 Jun 06; 9(9):583-90. PubMed ID: 9861520
    [Abstract] [Full Text] [Related]

  • 5. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Jun 06; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 6. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.
    Transplant Proc; 2004 Sep 06; 36(7):2141-4. PubMed ID: 15518777
    [Abstract] [Full Text] [Related]

  • 7. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 06; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia: preliminary report.
    Knopp RH, Frolich JJ.
    Am J Cardiol; 1994 May 26; 73(14):39D-41D. PubMed ID: 8198023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 26; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 11. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Alaupovic P.
    Am J Kidney Dis; 2002 Jan 26; 39(1):67-75. PubMed ID: 11774104
    [Abstract] [Full Text] [Related]

  • 12. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia.
    Rindone JP, Hiller D, Arriola G.
    Pharmacotherapy; 1998 Jan 26; 18(4):836-9. PubMed ID: 9692657
    [Abstract] [Full Text] [Related]

  • 13. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
    Reyderman L, Kosoglou T, Cutler DL, Maxwell S, Statkevich P.
    Curr Med Res Opin; 2005 Aug 26; 21(8):1171-9. PubMed ID: 16083526
    [Abstract] [Full Text] [Related]

  • 14. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.
    Int J Cardiol; 2007 Apr 12; 117(1):64-74. PubMed ID: 16889855
    [Abstract] [Full Text] [Related]

  • 15. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
    Winkler K, Ablethauser CB, Gimpelewicz C, Bortolini M, Isaacsohn JL.
    Clin Ther; 2007 Sep 12; 29(9):1987-2000. PubMed ID: 18035198
    [Abstract] [Full Text] [Related]

  • 16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 12; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 17. Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of action.
    Winkler K, Abletshauser C, Hoffmann MM, Friedrich I, Baumstark MW, Wieland H, März W.
    J Clin Endocrinol Metab; 2002 Dec 12; 87(12):5485-90. PubMed ID: 12466341
    [Abstract] [Full Text] [Related]

  • 18. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L, Zhao SP, Hu M, Li JX.
    Coron Artery Dis; 2007 Sep 12; 18(6):489-93. PubMed ID: 17700222
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study.
    O'Rourke B, Barbir M, Mitchell AG, Yacoub MH, Banner NR.
    Int J Cardiol; 2004 Apr 12; 94(2-3):235-40. PubMed ID: 15093987
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.